The immunomodulatory properties of mesenchymal stem cells (MSCs)

Since their discovery in 1991, mesenchymal stem cells, or MSCs, have been used as a promising method to build tissue. However, MSCs can do more for the development of cell and gene therapies. Find out more in our video.

With the latest research, our understanding of the mechanisms induced by MSCs in therapeutic applications has shifted:

MSCs also provide therapeutic benefits in the host body via paracrine effects and the stimulation of host cells, as they can modulate the innate and adaptive immune responses. Indeed, MSCs not only serve as tissue progenitor cells, but they also have the ability to alter the tissue environment.

How does this work to result in a therapeutic potential? Learn more in our video.

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

 

Learn even more

Find out about the challenges and chances of MSCs in cancer therapy.

Read the article

Choose your Region

Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.

  1. North America
    1. Canada
    2. United States
  2. Europe
    1. Albania
    2. Austria
    3. Belgium
    4. Bosnia-Herzogovina
    5. Bulgaria
    6. Croatia
    7. Czech Republic
    8. Denmark
    9. Finland
    10. France
    11. Germany
    12. Greece
    13. Hungary
    14. Ireland
    15. Italy
    16. Liechtenstein
    17. Luxembourg
    18. Macedonia
    19. Monaco
    20. Netherlands
    21. Norway
    22. Poland
    23. Portugal
    24. Romania
    25. Serbia
    26. Slovakia
    27. Slovenia
    28. Spain
    29. Sweden
    30. Switzerland
    31. United Kingdom
  3. Asia
    1. India
    2. Indonesia
    3. Israel
    4. Japan
    5. Malaysia
    6. Singapore
    7. South Korea
    8. Taiwan
    9. Thailand
Scroll to top